Brief: Lucira Files For Authorization Of First-Of-Its-Kind Covid-19 & Flu At-Home Molecular Test
12/05/2022 12:01
May 12 (Reuters) - Lucira Health Inc LHDX.O :
* LUCIRA FILES FOR AUTHORIZATION OF FIRST-OF-ITS-KIND
COVID-19 &
FLU AT-HOME MOLECULAR TEST
Source text for Eikon: ID:nGNX95rxYJ
Further company coverage: LHDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lucira Health
See all newsBrief: Lucira Health Inc Filed Its Amended Chapter 11 Plan Of Liquidation With Bankruptcy Court
Brief: Lucira Health Files Proposed Chapter 11 Plan Of Liquidation
Brief: Bankruptcy Court Approves Lucira Health Assets Sale To Pfizer
Brief: Lucira Health Inc Says On April 6, 2023 Co Held Auction Relating To Disposition Of All Or Substantially All Of Company's Assets
Brief: Lucira Health Announces U.S. Launch Of First & Only At-Home Combination Covid-19 & Flu Test Amidst Sale Process